NASDAQ:CTOR | Profit Breakdown | CITIUS ONCOLOGY, INC.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2021-06-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$1.49M$1M-$8.72M-$9.03M-$8.92M
2026-03-31$1.67M$1.34M-$28.61M-$26.84M-$26.61M
2025-12-31$3.94M$3.15M-$5.25M-$5.27M-$5.53M
2025-09-30-$4.71M-$4.73M-$5M
2025-06-30-$4.94M-$5.11M-$5.37M
2025-03-31-$7.47M-$7.47M-$7.74M
2024-12-31-$6.39M-$6.39M-$6.66M
2024-09-30-$6.67M-$6.67M-$6.81M
2024-06-30-$4.63M-$4.63M-$4.77M
2024-03-31-$268,429.00-$4.69M-$4.84M
2023-12-31-$244,139.00-$4.58M-$4.73M
2023-09-30-$421,455.00$157,943.00
2023-06-30-$199,554.00$616,296.00
2023-03-31-$147,922.00$611,725.00
2021-06-30-$724.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-09-30-$23.52M-$23.7M-$24.76M
2024-09-30-$20.57M-$20.57M-$21.15M
2023-12-31-$1.01M$2.42M
2023-09-30-$12.12M-$12.7M
2022-12-31-$138,115.00$380,811.00